Clinical outcomes of BRAF plus MEK inhibition in melanoma: A meta‐analysis and systematic review

BACKGROUND: Melanoma is a potentially fatal malignancy with poor prognosis. Several recent studies have demonstrated that combination therapy of BRAF and MEK inhibition achieved better curative effect and appeared less toxic effects. We conducted a meta‐analysis to evaluate the efficacy and safety b...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Qingliang, Xie, Jiayi, Li, Jiangmiao, Lu, Yunxin, Liao, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745835/
https://www.ncbi.nlm.nih.gov/pubmed/31393083
http://dx.doi.org/10.1002/cam4.2248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745835/
https://www.ncbi.nlm.nih.gov/pubmed/31393083
http://dx.doi.org/10.1002/cam4.2248

Ejemplares similares